Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
THERAPY WITH BENZODIAZEPINES REVISED - A CLINICAL REVIEW
Autore:
LAUX G;
Indirizzi:
UNIV BONN,PSYCHIAT KLIN,SIGMUND FREUD STR 25 D-53105 BONN GERMANY
Titolo Testata:
Nervenarzt
fascicolo: 5, volume: 66, anno: 1995,
pagine: 311 - 322
SICI:
0028-2804(1995)66:5<311:TWBR-A>2.0.ZU;2-K
Fonte:
ISI
Lingua:
GER
Soggetto:
PSYCHOTROPIC-DRUG USE; PSYCHIATRIC-INPATIENTS; PANIC DISORDER; MEDICAL-PRACTICE; ABUSE; DEPENDENCE; ALPRAZOLAM; WITHDRAWAL; LORAZEPAM; DIAZEPAM;
Keywords:
BENZODIAZEPINES; PSYCHOTROPICS; TRANQUILIZER; HYPNOTICS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
91
Recensione:
Indirizzi per estratti:
Citazione:
G. Laux, "THERAPY WITH BENZODIAZEPINES REVISED - A CLINICAL REVIEW", Nervenarzt, 66(5), 1995, pp. 311-322

Abstract

Benzodiazepines are the psychotropics most frequently prescribed despite an impressive reduction in use in the last 10 years. Their main pharmacodynamic effects (anxiolytic, sedative, anticonvulsive, muscle-relaxing, amnestic) are the basis for various therapeutic applications and indications. The most important differences among the variety of benzodiazepines are pharmacokinetic ones (elimination half-life, formation of pharmacologically active metabolites). Established indications are anxiety and sleep disorders, seizures, epilepsy, premedication and sedation in emergency medicine. In recent years it has also been proven to be effective in the treatment of panic disorder and catatonia. Among the side effects seen most frequently are impairments of cognitiveand psychomotor function as well as rebound phenomena. Discussions have recently focused on the incidence of abuse and dependence as well as case reports on severe amnesia. Alternative medications like neuroleptics in low dosage and antidepressants seem to be predominantly unfavorable due to the fact that they are tolerated less well and sometimeshave severe side effects. A clear-cut indication and time-limited prescription can reduce the number of benzodiazepine long-term users, anda comprehensive treatment concept must be the basis of rational prescription of benzodiazepines. The positive benefit-risk ratio as well asresearch perspectives [identification of receptor subtypes, development of highly selective ligands and partial (inverse) agonists] are reasons for assuming that the era of the benzodiazepines has not come to an end.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/07/20 alle ore 20:28:46